[Commentary to the article: Swedberg K, Komajda M, Böhm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 2010; DOI:10.1016/S01406736(10)61198-1].
Lukasz
L
Kołtowski